SG

Sitam Guru

Active Director Director DIN 11209793
DIN 11209793 First appointment Jul 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Sitam Guru

Data last updated:

Sitam Guru is a Director at Healtron Biotech Private Limited (since 2025). The company operates in Chemicals. Healtron Biotech Private Limited reported revenue of ₹12,600 (FY 2024).

DIN 11209793
Primary Designation Director
Industry Chemicals
First Appointment 24 Jul 2025
Oldest Company Age 5 yrs
Largest company Healtron Biotech Private Limited · ₹12,600 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healtron Biotech Private Limited U24290OR2021PTC035780
Director24 Jul 20252021₹12,600 (FY 2024)Active

Board colleagues of Sitam Guru

NameDINCompanyDesignation
Manas Kumar Barick10942533Healtron Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Healtron Biotech Private Limited
Premium access

Shareholding and investment profile for Sitam Guru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sitam Guru

Sitam Guru currently holds 1 directorship: Healtron Biotech Private Limited (Director, since 24 Jul 2025, revenue ₹12,600 (FY 2024)).

Sitam Guru was first appointed on 24 Jul 2025 as Director at Healtron Biotech Private Limited.

The current boards of Sitam Guru's companies include Manas Kumar Barick (Healtron Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available